Skip to Main Content

Paper Details

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies.
Cancer Discov
60
2022
Patients, Pediatric, Recurrent Malignancies, cancer, cfDNA, children, circulating cell-free DNA, extracerebral tumors, patients, tumor
Author NameAffiliation
Ga??lle PierronHospital Group, Institut Curie
Mathieu ChicardINSERM U, Research Center, PSL Research University, Institut Curie
Olivier DelattreINSERM U, Research Center, PSL Research University, Institut Curie
Olivier DelattreInstitut Curie Genomics of Excellence (ICGex) Platform, Research Center, Institut Curie
Olivier DelattreSIREDO Oncology Center (Care, Institut Curie, PSL Research University
Gilles VassalClinical Research Direction, Universite Paris-Saclay
Gudrun SchleiermacherINSERM U, Research Center, PSL Research University, Institut Curie
Gudrun SchleiermacherSIREDO Oncology Center (Care, Institut Curie, PSL Research University
  • 1 - 8

Datasets